Rohto Pharmaceutical Co Ltd
TSE:4527

Watchlist Manager
Rohto Pharmaceutical Co Ltd Logo
Rohto Pharmaceutical Co Ltd
TSE:4527
Watchlist
Price: 2 808.5 JPY 2.31% Market Closed
Market Cap: 642.5B JPY
Have any thoughts about
Rohto Pharmaceutical Co Ltd?
Write Note

Operating Margin
Rohto Pharmaceutical Co Ltd

13.1%
Current
15%
Average
5.5%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.1%
=
Operating Profit
36.9B
/
Revenue
282.1B

Operating Margin Across Competitors

Country JP
Market Cap 640.7B JPY
Operating Margin
13%
Country FR
Market Cap 176B EUR
Operating Margin
19%
Country UK
Market Cap 117.3B GBP
Operating Margin
18%
Country IN
Market Cap 5.7T INR
Operating Margin
22%
Country UK
Market Cap 34.7B GBP
Operating Margin
19%
Country DE
Market Cap 27.7B EUR
Operating Margin
11%
Country US
Market Cap 25.1B USD
Operating Margin
10%
Country JP
Market Cap 2.9T JPY
Operating Margin
7%
Country IN
Market Cap 1.2T INR
Operating Margin
21%
Country IN
Market Cap 909.1B INR
Operating Margin
15%
Country US
Market Cap 10.2B USD
Operating Margin
19%
No Stocks Found

Rohto Pharmaceutical Co Ltd
Glance View

Market Cap
640.7B JPY
Industry
Consumer products

Rohto Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, cosmetics, and functional food items. The company is headquartered in Osaka, Osaka-Fu and currently employs 6,596 full-time employees. The firm primarily provides eye care-related products, including eye drops and eye lotions; skin care-related products, including dermatological preparations, lip balms, sunscreens and functional cosmetics; oral medication and food-related products, including digestive medicines, Chinese herbal medicines and supplements, as well as extracorporeal test drugs and other products. The firm operates its business in domestic market and overseas markets, including Europe, Asia and America.

Intrinsic Value
3 343.8 JPY
Undervaluation 16%
Intrinsic Value
Price

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
13.1%
=
Operating Profit
36.9B
/
Revenue
282.1B
What is the Operating Margin of Rohto Pharmaceutical Co Ltd?

Based on Rohto Pharmaceutical Co Ltd's most recent financial statements, the company has Operating Margin of 13.1%.